{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:13:39Z","timestamp":1768295619065,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00802-w","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:59:40Z","timestamp":1762495180000},"page":"303-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u0395ffects of MTR and AS3MT variants on antipsychotic response: prospective evidence from a naturalistic study in Greece"],"prefix":"10.1007","volume":"78","author":[{"given":"Charikleia","family":"Ntenti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalini","family":"Filippiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domniki","family":"Loukaki-Gkountara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis","family":"Goulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"802_CR1","unstructured":"VizHub - GBD Results [Internet]. [cited 2025 May 19]. Available from: https:\/\/vizhub.healthdata.org\/gbd-results\/"},{"key":"802_CR2","doi-asserted-by":"publisher","unstructured":"Owen MJ, Legge SE, Rees E, Walters JTR, O\u2019Donovan MC. Genomic findings in schizophrenia and their implications. Mol Psychiatry [Internet]. 2023 [cited 2025 May 19];28:3638\u201347. Available from: https:\/\/doi.org\/10.1038\/s41380-023-02293-8","DOI":"10.1038\/s41380-023-02293-8"},{"key":"802_CR3","doi-asserted-by":"publisher","unstructured":"Leucht S, Priller J, Davis JM. Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application. Am J Psychiatry [Internet]. 2024 [cited 2025 May 5];181:8 65\u201378. Available from: https:\/\/doi.org\/10.1176\/appi.ajp.20240738","DOI":"10.1176\/appi.ajp.20240738"},{"key":"802_CR4","doi-asserted-by":"publisher","unstructured":"Arranz MJ, Rivera M, Munro JC. Pharmacogenetics of response to antipsychotics in patients with schizophrenia. CNS Drugs [Internet]. 2011 [cited 2025 May 5];25:933\u201369. Available from: https:\/\/doi.org\/10.2165\/11595380-000000000-00000","DOI":"10.2165\/11595380-000000000-00000"},{"key":"802_CR5","doi-asserted-by":"publisher","unstructured":"Arranz MJ, Gallego C, Salazar J, Arias B. Pharmacogenetic studies of drug response in schizophrenia. Expert Rev Precis Med Drug Dev [Internet]. 2016 [cited 2025 May 5];1:79\u201391. Available from: https:\/\/doi.org\/10.1080\/23808993.2016.1140554","DOI":"10.1080\/23808993.2016.1140554"},{"key":"802_CR6","doi-asserted-by":"publisher","unstructured":"Shad MU. Genetic testing for antipsychotic pharmacotherapy: bench to bedside. Behavi Sci [Internet]. 2021 [cited 2025 May 5];11:97. Available from: https:\/\/doi.org\/10.3390\/bs11070097","DOI":"10.3390\/bs11070097"},{"key":"802_CR7","doi-asserted-by":"publisher","unstructured":"Arranz MJ, Salazar J, Hern\u00e1ndez MH. Pharmacogenetics of antipsychotics: clinical utility and implementation. Behav Brain Res [Internet]. 2021 [cited 2025 May 5];401:113058. Available from: https:\/\/doi.org\/10.1016\/j.bbr.2020.113058","DOI":"10.1016\/j.bbr.2020.113058"},{"key":"802_CR8","doi-asserted-by":"publisher","unstructured":"Drogemoller BI, Emsley R, Chiliza B, Van Der Merwe L, Wright GEB, Daya M, et al. The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients. Pharmacogenet Genomics [Internet]. 2016 [cited 2025 May 5];26:235\u201342. Available from: https:\/\/doi.org\/10.1097\/FPC.0000000000000213","DOI":"10.1097\/FPC.0000000000000213"},{"key":"802_CR9","doi-asserted-by":"publisher","unstructured":"Roffman JL, Lamberti JS, Achtyes E, Macklin EA, Galendez GC, Raeke LH, et al. Randomized multicenter investigation of Folate Plus Vitamin B12 supplementation in schizophrenia. JAMA Psychiatry [Internet]. 2013 [cited 2025 May 5];70:481\u20139. Available from: https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.900","DOI":"10.1001\/jamapsychiatry.2013.900"},{"key":"802_CR10","doi-asserted-by":"publisher","unstructured":"Mitchell ES, Conus N, Kaput J. B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci Biobehav Rev [Internet]. 2014 [cited 2025 May 5];47:307\u201320. Available from: https:\/\/doi.org\/10.1016\/j.neubiorev.2014.08.006","DOI":"10.1016\/j.neubiorev.2014.08.006"},{"key":"802_CR11","doi-asserted-by":"publisher","unstructured":"Taheri N, Pirboveiri R, Sayyah M, Bijanzadeh M, Ghandil P. Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia. BMC Psychiatry [Internet]. 2023 [cited 2025 May 5];23:1\u201310. Available from: https:\/\/doi.org\/10.1186\/s12888-023-05292-9","DOI":"10.1186\/s12888-023-05292-9"},{"key":"802_CR12","doi-asserted-by":"publisher","unstructured":"Zhao W, Zhang Q, Chen X, Li Y, Li X, Du B, et al. The VNTR of the AS3MT gene is associated with brain activations during a memory span task and their training-induced plasticity. Psychol Med [Internet]. 2020 [cited 2025 May 5];51:1927. Available from: https:\/\/doi.org\/10.1017\/S0033291720000720","DOI":"10.1017\/S0033291720000720"},{"key":"802_CR13","doi-asserted-by":"publisher","unstructured":"Obermeier M, Schennach-Wolff R, Meyer S, M\u00f6ller HJ, Riedel M, Krause D, et al. Is the PANSS used correctly? A systematic review. BMC Psychiatry [Internet]. 2011 [cited 2025 May 5];11:1\u20135. Available from: https:\/\/doi.org\/10.1186\/1471-244X-11-113","DOI":"10.1186\/1471-244X-11-113"},{"key":"802_CR14","doi-asserted-by":"publisher","unstructured":"Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, Hoda F, et al. High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson\u2019s disease. Neurosci Lett [Internet]. 1997 [cited 2025 May 6];221:202\u20134. Available from: https:\/\/doi.org\/10.1016\/s0304-3940(96)13289-4","DOI":"10.1016\/s0304-3940(96)13289-4"},{"key":"802_CR15","doi-asserted-by":"publisher","unstructured":"Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, et al. Gene-qg ene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet [Internet]. 2004 [cited 2025 May 5];41:256\u201360. Available from: https:\/\/doi.org\/10.1136\/jmg.2003.010694","DOI":"10.1136\/jmg.2003.010694"},{"key":"802_CR16","doi-asserted-by":"publisher","unstructured":"Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (Vitamin B12) increases risk for spina bifida. Mol Genet Metab [Internet]. 1999 [cited 2025 May 5];67:317\u201323. Available from: https:\/\/doi.org\/10.1006\/mgme.1999.2879","DOI":"10.1006\/mgme.1999.2879"},{"key":"802_CR17","doi-asserted-by":"publisher","unstructured":"Korovaitseva GI, Gabaeva MV, Yunilainen OA, Golimbet VE. Effect of VNTR polymorphism of the AS3MT gene and obstetrical complications on the severity of schizophrenia. Bull Exp Biol Med [Internet]. 2019 [cited 2025 May 5];168:84\u20136. Available from: https:\/\/doi.org\/10.1007\/s10517-019-04653-3","DOI":"10.1007\/s10517-019-04653-3"},{"key":"802_CR18","doi-asserted-by":"publisher","unstructured":"Li A, Shi Y, Xu L, Zhang Y, Zhao H, Li Q, et al. A possible synergistic effect of MTHFR C677T polymorphism on homocysteine level variations increased risk for ischemic stroke. Medicine (United States) [Internet]. 2017 [cited 2025 May 6];96. Available from: https:\/\/doi.org\/10.1097\/MD.0000000000009300","DOI":"10.1097\/MD.0000000000009300"},{"key":"802_CR19","doi-asserted-by":"publisher","unstructured":"Nazki FH, Sameer AS, Ganaie BA. Folate: Metabolism, genes, polymorphisms and the associated diseases. Gene [Internet]. 2014 [cited 2025 May 5];533:11\u201320. Available from: https:\/\/doi.org\/10.1016\/j.gene.2013.09.063","DOI":"10.1016\/j.gene.2013.09.063"},{"key":"802_CR20","doi-asserted-by":"publisher","unstructured":"Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JWG, Young IS, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol [Internet]. 1999 [cited 2025 Aug 15];17:298\u2013309. Available from: https:\/\/doi.org\/10.1002\/(SICI)1098-2272(199911)17:4%3C298::AID-GEPI5%3E3.0.CO;2-V","DOI":"10.1002\/(SICI)1098-2272(199911)17:4%3C298::AID-GEPI5%3E3.0.CO;2-V"},{"key":"802_CR21","doi-asserted-by":"publisher","unstructured":"Roffman JL, Petruzzi LJ, Tanner AS, Brown HE, Eryilmaz H, Ho NF, et al. Biochemical, physiologic, and clinical effects of L-methylfolate in schizophrenia: a randomized controlled trial. Mol Psychiatry [Internet]. 2017 [cited 2025 May 5];23:316. Available from: https:\/\/doi.org\/10.1038\/mp.2017.41","DOI":"10.1038\/mp.2017.41"},{"key":"802_CR22","doi-asserted-by":"publisher","unstructured":"Hill M, Shannahan K, Jasinski S, Macklin EA, Raeke L, Roffman JL, et al. Folate supplementation in schizophrenia: a possible role for MTHFR genotype. Schizophr Res [Internet]. 2011 [cited 2025 May 5];127:41\u20135. Available from: https:\/\/doi.org\/10.1016\/j.schres.2010.12.006","DOI":"10.1016\/j.schres.2010.12.006"},{"key":"802_CR23","doi-asserted-by":"publisher","unstructured":"Lam NSK, Long XX, Li X, Saad M, Lim F, Doery JC, et al. The potential use of folate and its derivatives in treating psychiatric disorders: a systematic review. Biomed Pharmacother [Internet]. 2022 [cited 2025 Aug 15];146:112541. Available from: https:\/\/doi.org\/10.1016\/j.biopha.2021.112541","DOI":"10.1016\/j.biopha.2021.112541"},{"key":"802_CR24","doi-asserted-by":"publisher","unstructured":"Joober R, Benkelfat C, Lal S, Bloom D, Labelle A, Lalonde P, et al. Association between the methylenetetrahydrofolate reductase 677\u00a0C\u2192T missense mutation and schizophrenia. Mol Psychiatry [Internet]. 2000 [cited 2025 May 5];5:323\u20136. Available from: https:\/\/doi.org\/10.1038\/sj.mp.4000724","DOI":"10.1038\/sj.mp.4000724"},{"key":"802_CR25","doi-asserted-by":"publisher","unstructured":"Roffman JL, Brohawn DG, Nitenson AZ, MacKlin EA, Smoller JW, Goff DC. Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia. Schizophr Bull [Internet]. 2011 [cited 2025 May 6];39:330. Available from: https:\/\/doi.org\/10.1093\/schbul\/sbr150","DOI":"10.1093\/schbul\/sbr150"},{"key":"802_CR26","doi-asserted-by":"publisher","unstructured":"Li M, Jaffe AE, Straub RE, Tao R, Shin JH, Wang Y, et al. A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. Nature Medicine 2016 22:6 [Internet]. 2016 [cited 2025 May 5];22:649\u201356. Available from: https:\/\/doi.org\/10.1038\/nm.4096","DOI":"10.1038\/nm.4096"},{"key":"802_CR27","doi-asserted-by":"publisher","unstructured":"Cai X, Yang ZH, Li HJ, Xiao X, Li M, Chang HA. Human-specific schizophrenia risk tandem repeat affects alternative splicing of a human-unique isoform AS3MTd2d3 and mushroom dendritic spine density. Schizophr Bull [Internet]. 2020 [cited 2025 May 5];47:219. Available from: https:\/\/doi.org\/10.1093\/schbul\/sbaa098","DOI":"10.1093\/schbul\/sbaa098"},{"key":"802_CR28","doi-asserted-by":"publisher","unstructured":"Huang MC, Douillet C, Su M, Zhou K, Wu T, Chen W, et al. Metabolomic profiles of arsenic (+\u20093 oxidation state) methyltransferase knockout mice: effect of sex and arsenic exposure. Arch Toxicol [Internet]. 2016 [cited 2025 May 5];91:189. Available from: https:\/\/doi.org\/10.1007\/s00204-016-1676-0","DOI":"10.1007\/s00204-016-1676-0"},{"key":"802_CR29","doi-asserted-by":"publisher","unstructured":"Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R. Methylenetetrahydrofolate reductase and psychiatric diseases. Translational Psychiatry 2018 8:1 [Internet]. 2018 [cited 2025 May 5];8:1\u201312. Available from: https:\/\/doi.org\/10.1038\/s41398-018-0276-6","DOI":"10.1038\/s41398-018-0276-6"},{"key":"802_CR30","doi-asserted-by":"publisher","unstructured":"Araszkiewicz AF, Ja\u0144czak K, W\u00f3jcik P, Bia\u0142ecki B, Kubiak S, Szczechowski M, et al. MTHFR Gene polymorphisms: a single gene with wide-ranging clinical implications\u2014a review. Genes. 2025;16:441 [Internet]. 2025 [cited 2025 Aug 15];16:441. Available from: https:\/\/doi.org\/10.3390\/genes16040441","DOI":"10.3390\/genes16040441"},{"key":"802_CR31","unstructured":"Khan KM, Jialal I. Folic acid deficiency. StatPearls [Internet]. 2023 [cited 2025 May 5]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535377\/"},{"key":"802_CR32","doi-asserted-by":"publisher","unstructured":"Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M et al. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PLoS One [Internet]. 2016 [cited 2025 May 5];11:e0146797. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0146797","DOI":"10.1371\/journal.pone.0146797"},{"key":"802_CR33","doi-asserted-by":"publisher","unstructured":"Misir E, Ozbek MM, Halac E, Turan S, Alkas GE, Ciray RO, et al. The effects of catechol-O-methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: a systematic review and meta-analysis. Psych J [Internet]. 2022 [cited 2025 May 5];11:779\u201391. Available from: https:\/\/doi.org\/10.1002\/pchj.562","DOI":"10.1002\/pchj.562"},{"key":"802_CR34","doi-asserted-by":"publisher","unstructured":"Ma J, Zhao M, Zhou W, Li M, Huai C, Shen L, et al. Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: an updated meta-analysis. Curr Neuropharmacol [Internet]. 2020 [cited 2025 May 5];19:1780\u201390. Available from: https:\/\/doi.org\/10.2174\/1570159X18666201023154049","DOI":"10.2174\/1570159X18666201023154049"},{"key":"802_CR35","doi-asserted-by":"publisher","unstructured":"Huang E, Zai CC, Lisoway A, Maciukiewicz M, Felsky D, Tiwari AK, et al. Catechol-O-Methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta-analysis. Internat J Neuropsychopharmacol [Internet]. 2016 [cited 2025 May 5];19:pyv132. Available from: https:\/\/doi.org\/10.1093\/ijnp\/pyv132","DOI":"10.1093\/ijnp\/pyv132"},{"key":"802_CR36","doi-asserted-by":"publisher","unstructured":"Noohi F, Boyden NB, Kwak Y, Humfleet J, Burke DT, M\u00fcller MLTM, et al. Association of COMT val158met and DRD2 G\u2009>\u2009T genetic polymorphisms with individual differences in motor learning and performance in female young adults. J Neurophysiol [Internet]. 2013 [cited 2025 Sep 10];111:628. Available from: https:\/\/doi.org\/10.1152\/jn.00457.2013","DOI":"10.1152\/jn.00457.2013"},{"key":"802_CR37","doi-asserted-by":"publisher","unstructured":"van der Burg KP, Cribb L, Firth J, Karmacoska D, Sarris J. Nutrient and genetic biomarkers of nutraceutical treatment response in mood and psychotic disorders: a systematic review. Nutr Neurosci [Internet]. 2021 [cited 2025 Aug 15];24:279\u201395. Available from: https:\/\/doi.org\/10.1080\/1028415X.2019.1625222","DOI":"10.1080\/1028415X.2019.1625222"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00802-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00802-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00802-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:49:50Z","timestamp":1768265390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00802-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00802-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants. The study was approved by the Scientific Board of the Psychiatric Hospital of Thessaloniki (Prot. Nr 7\/09-05-2017) and by the Bioethics Committee of the School of Medicine of the Aristotle University of Thessaloniki (13306\/29-06-2017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}